Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Horowitz, MD
Center for International Blood and Marrow Transplant Research
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope National Medical Center
Duarte, California, United States
- Stanford Hospital and Clinics
Stanford, California, United States
- University of Florida College of Medicine
Gainesville, Florida, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Blood & Marrow Transplant Program at Northside Hospital
Atlanta, Georgia, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- University of Kansas Hospital
Kansas City, Kansas, United States
- University of Kentucky
Lexington, Kentucky, United States
- Johns Hopkins/skccc
Baltimore, Maryland, United States
- Dana Farber Cancer Institute/brigham & Women'S
Boston, Massachusetts, United States
- Dana Farber Cancer Institute/massachusetts General Hospital
Boston, Massachusetts, United States
- Mayo Clinic - Rochester
Rochester, Minnesota, United States
- Washington University/barnes Jewish Hospital
St Louis, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Columbia University Medical Center
New York, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Weill Cornell Medical Center/new York Presbyterian
New York, New York, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University Hospitals of Cleveland/case Western
Cleveland, Ohio, United States
- Ohio State/arthur G. James Cancer Hospital
Columbus, Ohio, United States
- University of Oklahoma
Oklahoma City, Oklahoma, United States
- Oregon Health and Science University
Portland, Oregon, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Virginia Commonwealth University/mcv Hospitals
Richmond, Virginia, United States
- University of Wisconsin Hospital & Clinics
Madison, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2015
- Primary completion
- 5 Oct 2020
- Completion
- 5 Oct 2020
- Last update posted
- 7 Mar 2023
- Registered enrollment
- 346
- Registry id
- NCT02345850
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.